Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) reached a new 52-week low during mid-day trading on Friday . The company traded as low as $52.25 and last traded at $52.25, with a volume of 0 shares trading hands. The stock had previously closed at $52.25.
Analysts Set New Price Targets
Several equities analysts have recently commented on the stock. Royal Bank of Canada raised shares of Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research note on Monday, October 7th. Barclays upgraded Recordati Industria Chimica e Farmaceutica to a “strong sell” rating in a report on Tuesday, October 22nd.
Read Our Latest Analysis on Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%. The firm had revenue of $622.00 million for the quarter.
About Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Stories
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Stock Dividend Cuts Happen Are You Ready?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the Dow Jones Industrial Average (DJIA)?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.